Telix Pharmaceuticals

filter Active Ingredients

All (2)

01 GALLIUM GA-68 GOZETOTIDE (1)

02 Gallium (1)

filter Applicant

All (2)

01 TELIX (1)

02 Telix Pharmaceuticals (1)

filter Dosage Form

All (2)

01 POWDER FOR SOLUTION (1)

02 POWDER;INTRAVENOUS (1)

filter Dosage

All (2)

01 25MCG/VIAL (1)

02 N/A (1)

filter Country

All (2)

01 Canada (1)

02 USA (1)

Telix Pharmaceuticals's list of EU CTD Dossiers, Marketing Authorizations, In, Out Licensing Opportunities & Finished Dosage Formulations aggregated by PharmaCompass

About

Contact Details

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

VIDEO(s)

DIGITAL CONTENT

128 News

APIs // Active Pharmaceutical Ingredients

2 APIs

2 USDMF

DEVELOPMENTS

25 Drug(s) in Development

DOSSIERs // Finished Dosage Forms

2 Dossiers

1 FDA Orange Book

1 Canada

Telix Pharmaceuticals

Gallium

POWDER FOR SOLUTION

25MCG/VIAL

ILLUCCIX

Canada

2531836

Schedule C

GALLIUM GA-68 GOZETOTIDE

POWDER;INTRAVENOUS

N/A

ILLUCCIX

USA

214032

2021-12-17

RX